Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Clinical trial NCT07026149 · RECRUITING

Trial details

NCT number: NCT07026149
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

Start date: 2025-06-08
Primary completion: 2025-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.